Pluristem Therapeutics, Inc., an Israeli based company developing placenta-based cell therapies, and New York University (NYU) Medical Center today announced the formation of a partnership to study the use of Pluristem’s proprietary placenta-derived PLX cells for the treatment of diabetic foot ulcers...
Category: Diabetes Complications
A statin drug (Lipitor) may help prevent blindness in people with diabetes, according to researchers at the University of Georgia College of Pharmacy. In a study using diabetic rats and isolated retinal cells cultured in high glucose, lead author Azza El-Remessy, assistant professor in the University of Georgia College of Pharmacy...
Harvard University and Hebrew University scientists have developed a low cost, nanometer-sized drug to treat chronic wounds, such as diabetic foot ulcers or burns.
Several proteins, called growth factors, have been found to speed up the healing process, however purifying these growth factor proteins is very expensive, and they do not last long on the injured site....
The European Commission has granted Novartis a new indication for Lucentis (ranibizumab) to treat patients with visual impairment due to diabetic macular edema (DME) following two Novartis-sponsored clinical trials, RESTORE and RESOLVE. The trials showed that Lucentis was superior in providing rapid and sustained visual acuity gain versus placebo therapy or laser therapy..
Dermagraft is an advanced wound care product that contains living human skin cells...
Novartis has announced that it has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for Lucentis (ranibizumab) for the treatment of patients with visual impairment due to diabetic macular edema (DME).
The submission was supported by data from two Novartis-funded clinical trials, RESTORE and RESOLVE, which showed that Lucentis...
My doctors told me I would never have children and I would probably not live past 35. It was then that I made a promise to myself to never give up...
A new study published in the Journal of the American Medical Association suggests that nearly 30 percent of U.S. diabetics over the age of 40 may have a diabetes-related eye disorder, with 4 percent of this population affected severely enough that their vision is threatened...
As a child with diabetes, one of the most frightening reminders of the danger of the disease was the emergency glucagon kit. Not only was it a symbol of the terrifying risk of severe hypoglycemia...
According to a new study published online in Diabetologia, obese adolescents with type 2 diabetes may experience changes in their brains that affect how well they are learning in school. Cognitive and brain impairments, have been documented in adults with type 2 diabetes...